Liver transplant survival rate sees improvement among older adults

October 22, 2018

An increasing number of older adults are diagnosed with end-stage liver disease. End-stage liver disease is a life-threatening condition in which the liver stops working normally. It can be caused by hepatitis, alcoholism, cancer, and other conditions. A liver transplant is the only treatment for end-stage liver disease.

Although older adults make up almost 24 percent of people waiting for liver transplants, they have often not been considered candidates for receiving this life-saving surgery. That's because older adults often do poorly following liver transplant surgery. One reason for this is that older adults with liver disease often have many other health challenges which make recovery from transplant surgery more difficult.

However, researchers have recently reported successful liver transplants in older adults--even in people who are in their 80's.

To learn more about older adults and liver transplants, a team of researchers studied information recorded by the Scientific Registry of Transplant Recipients (SRTR) from 2003 to 2016. The SRTR data system includes information about all liver donors, people on liver transplant wait lists, and people who have received transplants in the United States. The team's study was published in the Journal of the American Geriatrics Society.

The researchers learned that out of the 58,598 adults who received liver transplants, 8,627 (14.7 percent) were older adults. Of them:

The number of liver transplants performed in older adults each year increased substantially from 2003 to 2016. In 2016, 1,144 older adults received liver transplants (20.7 percent of all liver transplant recipients), up from 263 older recipients in 2003 (when older adults made up just 9.5 percent of all liver transplant recipients).

Recently, older adults have been doing better following liver transplants. When the researchers took all factors into account, the one-year acute rejection rate in 2013-2016 was 30 percent lower than it was in 2003-2006. Also, the risk of death was 57 percent lower than in 2003-2006.

The researchers also reported that survival in older liver transplant recipients improved steadily over time.

Older patients with end-stage liver disease and their healthcare providers should be aware of these findings. The researchers suggested that increased age on its own should not prevent older adults and their healthcare providers from considering liver transplants.
-end-
This summary is from "Liver Transplantation Among Older Adults" It appears online ahead of print in the Journal of the American Geriatrics Society. The study authors are Christine E. Haugen MD; Courtenay M. Holscher MD; Jacqueline Garonzik-Wang MD PhD; Marcos Pozo MD; Fatima Warsame BA; Mara McAdams-DeMarco PhD; and Dorry L. Segev, MD, PhD.

About the Health in Aging Foundation

This research summary was developed as a public education tool by the Health in Aging Foundation. The Foundation is a national non-profit established in 1999 by the American Geriatrics Society to bring the knowledge and expertise of geriatrics healthcare professionals to the public. We are committed to ensuring that people are empowered to advocate for high-quality care by providing them with trustworthy information and reliable resources. Last year, we reached nearly 1 million people with our resources through HealthinAging.org. We also help nurture current and future geriatrics leaders by supporting opportunities to attend educational events and increase exposure to principles of excellence on caring for older adults. For more information or to support the Foundation's work, visit http://www.HealthinAgingFoundation.org.

About the Journal of the American Geriatrics Society

Included in more than 9,000 library collections around the world, the Journal of the American Geriatrics Society (JAGS) highlights emerging insights on principles of aging, approaches to older patients, geriatric syndromes, geriatric psychiatry, and geriatric diseases and disorders. First published in 1953, JAGS is now one of the oldest and most impactful publications on gerontology and geriatrics, according to ISI Journal Citation Reports®. Visit wileyonlinelibrary.com/journal/JGS for more details.

About the American Geriatrics Society

Founded in 1942, the American Geriatrics Society (AGS) is a nationwide, not-for-profit society of geriatrics healthcare professionals that has--for 75 years--worked to improve the health, independence, and quality of life of older people. Its nearly 6,000 members include geriatricians, geriatric nurses, social workers, family practitioners, physician assistants, pharmacists, and internists. The Society provides leadership to healthcare professionals, policymakers, and the public by implementing and advocating for programs in patient care, research, professional and public education, and public policy. For more information, visit AmericanGeriatrics.org.

American Geriatrics Society

Related Liver Disease Articles from Brightsurf:

Fatty liver disease despite a normal weight
Researchers from the University of Tsukuba found significant differences in the clinical presentation of non-obese patients with non-alcoholic fatty liver disease (NAFLD) based on their sex and body mass index.

Sobering reminder about liver disease
Alcohol's popularity and its central place in socialising in Australia obscures the dangers of excessive drinking and possible liver disease, Flinders University experts warn.

Giant leap in diagnosing liver disease
A collaborative team of Salk Institute and UC San Diego scientists have created a novel microbiome-based diagnostic tool that, with the accuracy of the best physicians, quickly and inexpensively identifies liver fibrosis and cirrhosis over 90 percent of the time in human patients.

Link between liver and heart disease could lead to new therapeutics
A newly published study of flies found that protecting liver function also preserves heart health.

Fatty liver disease is underdiagnosed in the US
According to an analysis published in Alimentary Pharmacology & Therapeutics, nonalcoholic fatty liver disease (NAFLD) is grossly underdiagnosed in the United States.

Possible new treatment strategy for fatty liver disease
Researchers at Karolinska Institutet in Sweden have identified a molecular pathway that when silenced could restore the normal function of immune cells in people with fatty liver disease.

Longevity protein SIRT6 also protects against fatty liver and fatty liver disease
SIRT6 regulates fat metabolism by activating another protein called peroxisome proliferator-activated receptor alpha (PPAR-alpha).

Fresh insights could lead to new treatments for liver disease
The fight against liver disease could be helped by the discovery of cells that cause liver scarring.

Better methods needed for predicting risk of liver disease
While blood samples can reliably identify people with a low risk of developing severe liver disease, better methods are needed in primary care for identifying people in most need of care.

Lab-on-a-chip may help identify new treatments for liver disease
Investigators have developed a 'lab on a chip' technology that can simulate different levels of non-alcoholic fatty liver disease progression.

Read More: Liver Disease News and Liver Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.